## **Core Concept**
The question tests the understanding of **Cyclooxygenase (COX) enzymes**, specifically the difference between COX-1 and COX-2 isoforms, and their role in the inflammatory pathway. COX-2 inhibitors are a class of nonsteroidal anti-inflammatory drugs (NSAIDs) that selectively block the COX-2 enzyme, reducing inflammation and pain with potentially fewer gastrointestinal side effects compared to non-selective NSAIDs.

## **Why the Correct Answer is Right**
The correct answer, , is a well-known **selective COX-2 inhibitor**. It works by specifically blocking the COX-2 enzyme, which is primarily responsible for the inflammatory response. By inhibiting COX-2, reduces the production of prostaglandins, which are mediators of inflammation, pain, and fever. This selective inhibition is believed to minimize gastrointestinal side effects associated with COX-1 inhibition.

## **Why Each Wrong Option is Incorrect**
- **Option A:** is not a selective COX-2 inhibitor; it is actually a non-selective NSAID that inhibits both COX-1 and COX-2 enzymes.
- **Option B:** is also not a selective COX-2 inhibitor; it is another non-selective NSAID.
- **Option D:** is not classified as a selective COX-2 inhibitor; its mechanism or classification does not align with COX-2 selectivity.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that **selective COX-2 inhibitors** like were developed to reduce the gastrointestinal toxicity associated with traditional NSAIDs. However, their use has been limited by concerns about cardiovascular safety. It's crucial to weigh the benefits and risks when prescribing these drugs, especially in patients with cardiovascular risk factors.

## **Correct Answer:** .